Theranos was worth an estimated $9 billion at the height of media fervor around the company, which has since been revised down to just a fraction of that as the company has begun voiding its own test results. Holmes herself initially defended her company's processes, and at one point Theranos was trying to fend off harsh penalties that could have banned her from the blood testing industry entirely. After mining the 2008 financial crisis for some dark humor in his previous film The Big Short, Adam McKay is signed on to direct, so it's safe to say there's enough material there for a compelling storyline, especially one that feeds into Hollywood's recent obsession with Silicon Valley.